RENAL INVOLVEMENT IN MULTIPLE MYELOMA: A 10-YEAR STUDY

REFERENCES

• Editorial. Renal involvement in myeloma. Lancet 1988; 1: 1202–1203
   PubMed Web of Science ®Google Scholar
• Winearls C G. Acute myeloma kidney. Kidney Int 1995; 48: 1347–1361
   PubMed Web of Science ®Google Scholar
• Alexanian R, Barlogie B, Dixon D. Renal failure in multiple myeloma: pathogenesis and prognostic implications. Arch Intern Med 1990; 150: 1693–1695
   PubMed Web of Science ®Google Scholar
• Pasquali S, Casanova S, Zuccheli A, Zuccheli P. Long-term survival of patients with acute and severe renal failure due to multiple myeloma. Clin Nephrol 1990; 34: 247–254
   PubMed Web of Science ®Google Scholar
• Pozzi C, Pasquali S, Donini U, et al. Prognostic factors and effectiveness of treatment in acute renal failure due to multiple myeloma: a review of 50 cases. Clin Nephrol 1987; 28: 1–9
   PubMed Web of Science ®Google Scholar
• DeFronzo R E, Humphrey R L, Wright J R, Cooke C R. Acute renal failure in multiple myeloma. Medicine (Baltimore) 1975; 54: 209–223
   PubMed Web of Science ®Google Scholar
• Cosio F G, Pence T V, Shapiro F L, Kjellstrand C E. Severe renal failure in multiple myeloma. Clin Nephrol 1981; 4: 206–210
   Google Scholar
• Johnson W J, Kyle R A, Pineda A A, O'Brien P C, Holley K E. Treatment of renal failure associated with multiple myeloma. Plasmapheresis, hemodialysis and chemotherapy. Arch Intern Med 1990; 150: 863–869
   PubMed Web of Science ®Google Scholar
• Torra R, Bladé J, Cases A., et al. Patients with multiple myeloma requiring long term dialysis: Presenting features, response to therapy and outcome in a series of 20 cases. Br J Haematol 1995; 91: 854–859
   PubMed Web of Science ®Google Scholar
• Kyle R A. Multiple myeloma: A review of 869 cases. Mayo Clin Proc 1975; 50: 29–40
   PubMed Web of Science ®Google Scholar
• Alexanian R, Dimopoulos M. The treatment of multiple myeloma. N Engl J Med 1994; 330: 484–489
   PubMed Web of Science ®Google Scholar
• Durie B GM, Salmon S E. A clinical staging system for multiple myeloma. Correlation of measured myeloma cell mass with presenting clinical features, response to treatment and survival. Cancer 1976; 36: 842–854
   Web of Science ®Google Scholar
• Knudsen L M, Hippe E, Hjorth M, Holmberg E, Westin J. Renal function in newly diagnosed multiple myeloma. A demographic study of 1353 patients. Eur J Haematol 1994; 53: 207–212
   PubMed Web of Science ®Google Scholar
• MacLennan I CM, Cooper E H, Chapman C E, Kelly R A, Crockson R A. Renal failure in myelomatosis. Eur J Haematol 1989; 43(suppl 51)60–65
   Google Scholar
• MRC Working Party on Leukemia in Adults. Analysis and management of renal failure in the fourth MRC myelomatosis trial. Br Med J 1984; 288: 1411–1416
   PubMed Web of Science ®Google Scholar
• Kapadia S B. Multiple myeloma: A clinicopathologic study of 62 consecutively autopsied cases. Medicine (Baltimore) 1980; 59: 380–392
   PubMed Web of Science ®Google Scholar
• Martinez-Maldonado M, Yium J, Suki W N, Eknoyan G. Renal complications in multiple myeloma: pathophysiology and some aspects of clinical management. J Chron Dis 1971; 24: 221–237
   PubMedGoogle Scholar
• Rota S, Mougenot B, BauDOIn B, De Meyer Brasseur M, Le Maitre V, Michel C, Mignon F, Rondeau E, Vanttille P, Verroust P. Multiple myeloma and severe renal failure: a clinicopathological study of outcome and prognosis in 34 cases. Medicine (Baltimore) 1987; 66: 126–137
   PubMed Web of Science ®Google Scholar
• Johnson W J, Kyle R A, Dahlberg P J. Dialysis in the treatment of myeloma. Mayo Clin Proc 1980; 55: 65–72
   PubMed Web of Science ®Google Scholar
• Pasquali S, Zuccheli P, Casanova S, Cagnoli L, Conforloniri R, Pozzi C, Banfi G, Lupo A, Bertani T. Renal histological lesions and clinical syndromes in multiple myeloma. Clin Nephrol 1987; 27: 222–228
   PubMed Web of Science ®Google Scholar
• Cohen D J, Sherman W H, Osserman E F, Appel G B. Acute renal failure in patients with multiple myeloma. Am J Med 1984; 76: 247–256
   PubMed Web of Science ®Google Scholar
• Rayner H C, Haynes A P, Thompson J R, Russell N, Fletcher J. Perspectives in multiple myeloma: Survival, prognostic factors and disease complications in a single center between 1975 and 1988. Q J Med 1991; 79: 517–525
   PubMedGoogle Scholar
• Zuccheli P, Pasquali S, Cagnoli L, Ferrari G. Controlled plasma exchange trial in acute renal failure due to multiple myeloma. Kidney Int 1988; 33: 1175–1180
   PubMed Web of Science ®Google Scholar
• McCarthy C S, Becker J A. Multiple myeloma and contrast media. Radiology 1992; 183: 519–521
   PubMed Web of Science ®Google Scholar
• Bladé J, Lust J A, Kyle R A. Immunoglobulin D multiple myeloma: presenting features, response to therapy, and survival in a series of 53 cases. J Clin Oncol 1994; 12: 2398–2404
   PubMed Web of Science ®Google Scholar
• Ganeval D, Noel L N, Preud' homme J L, Droz D, Grunfeld J P. Light chain deposition disease: its relation with AL type amyloidosis. Kidney Int 1984; 26: 1–9
   PubMed Web of Science ®Google Scholar
• Ivanyi B. Frequency of light chain deposition nephropathy relative to renal amyloidosis and Bence-Jones cast nephropathy in a necropsy study of patients with myeloma. Arch Pathol Lab Med 1990; 114: 986–987
   PubMed Web of Science ®Google Scholar
• Pirani C L, Silva F, D'Agati V, Chander P, Striker L. Multiple myeloma. Renal lesions in plasma cell dyscrasias: Ultrastructural observations. Am J Kidney Dis 1987; 10: 208–221
   PubMed Web of Science ®Google Scholar
• Border W A, Cohen A H. Renal biopsy diagnosis of clinically silent multiple myeloma. Ann Intern Med 1980; 93: 43–46
   PubMed Web of Science ®Google Scholar
• Sanders P W, Booker B B. Pathobiology of cast nephropathy from human Bence-Jones proteins. J Clin Invest 1992; 89: 630–639
   PubMed Web of Science ®Google Scholar
• Iggo N, Palmer A B, Severn A, Tafford J A, Mufti G J, Taube D, Parsons V. Chronic dialysis in patients with myeloma and renal failure: a worthwhile treatment. QJ Med 1989; 73: 903–910
   PubMedGoogle Scholar
• Korzets A, Tam F, Russell G, Feehally J, Walls J. The role of continuous ambulatory peritoneal dialysis in end-stage renal failure due to myeloma. Am J Kidney Dis 1990; 16: 216–223
   PubMed Web of Science ®Google Scholar
• Hannisdal E, Kildahl-Anderson O, Grottum K A, Lamvik J. Prognostic factors in multiple myeloma in a population based trial. Eur J Haematol 1990; 45: 198–202
   PubMed Web of Science ®Google Scholar
• Coward R A, Mallick N P, Delamore J W. Should patients with renal failure associated with myeloma be dialysed?. Br Med J 1983; 287: 1575–1578
   PubMedGoogle Scholar
• Bernstein S P, Humes N D. Reversible renal insufficiency in multiple myeloma. Arch Intern Med 1982; 142: 2083–2086
   PubMedGoogle Scholar
• Misiani R, Tirabaschi G, Mingardi G, Mecca G. Management of myeloma kidney: An anti-light chain approach. Am J Kidney Dis 1987; 10: 28–33
   PubMed Web of Science ®Google Scholar
• Rose P E, McGonigle R, Michael J, Biughton B J. Renal failure and the histopathological features of myeloma kidney reversed by intensive chemotherapy and peritoneal dialysis. Br Med J 1987; 294: 411–412
   PubMedGoogle Scholar
• Cavo M, Baccarani M, Galieni P, Gobbi M, Tura S. Renal failure in multiple myeloma: A study of the presenting findings, response to treatment and prognosis in 26 patients. Nouv Rev Fr Hematol 1986; 28: 147–152
   PubMedGoogle Scholar
• Ganeval D, Jungers P, Noel L H, Droz D. La nephropathie du my—lome. Actualites nephrologiques de Hospital Necker, J Hamburger, J Crosnier, J L Funck-Brentano. Flammarion, Paris 1977; 309–347
   Google Scholar
• Penn I. Kidney transplantation following treatment of tumors. Transplant Proc 1986; 18(suppl 3)16–20
   Google Scholar
• Wahlin A, Lofvenberg E, Holm J. Improved survival in multiple myeloma with renal failure. Acta Med Scand 1987; 221: 205–209
   PubMedGoogle Scholar